Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes. Biomol Biomed [Internet]. 2023 Mar. 16 [cited 2024 May 4];23(2):189–190. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/8874